Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Comment by JDavenporton Oct 28, 2022 9:40pm
130 Views
Post# 35057322

RE:RE:From the MD&A...

RE:RE:From the MD&A...Bwah hahahahaha!

I knew you couldn't figure it out, beenthere. I was so hoping that Bioasis would release their financials today. You can't read  the schedule I posted, You can't figure it out.

The deadline, as I said, is Monday, October 21. Bioasis, like most companies, is early. I posted the OSC calendar so that if Bioasis didn't file today then it was no big deal because they have until Monday. By the way, the deadline is not always the last day of the month.

Oh, you say, that's the OSC, not BC, schedulae. I was waiting for that one, too.

Here's the BC schedule, but it's harder to read than the OSC one. They're the same, beenthere, for obvious reasons.

beenthere, you should never have been in this game.

jd
<< Previous
Bullboard Posts
Next >>